Bruker Corp BRKR
$56.46 −$5.64 (-9.08%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $56.46 0.00%
Open$60.65
Prev close$62.10
Day range$56.13 – $61.10
Volume2.25M
Market cap$8.62B
P/E (TTM)–
Dividend yield0.35%
BRKR Stock News
Headlines matching Bruker Corp or the BRKR ticker, most recent first.
- Leerink Partners Maintains Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $80
- J.P. Morgan Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $60 Negative
- BofA Securities Maintains Bruker Corp(BRKR.US) With Buy Rating
- Citi Maintains Bruker Corp(BRKR.US) With Hold Rating, Cuts Target Price to $53 Negative
- Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $70
- Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $58 Negative
- Citi Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $60 Positive
- Analysts Offer Insights on Healthcare Companies: MannKind (MNKD), Bruker (BRKR) and BrightSpring Health Services, Inc. (BTSG)
- Goldman Sachs Maintains Bruker Corp(BRKR.US) With Sell Rating, Maintains Target Price $40
- Goldman Sachs Maintains Bruker Corp(BRKR.US) With Sell Rating, Raises Target Price to $40 Positive
- TD Cowen Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $60 Positive
- J.P. Morgan Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $65 Positive
- Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $70 Positive
- Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $60 Positive
- BofA Securities Maintains Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $65
No comments yet — be the first to weigh in on BRKR.
Sign in to join the discussion.